https://european-biotechnology.net/wp-content/uploads/2025/06/SpliceBIO_1000_F_519755111_rUPdIJpqSq9yoHeMgs7izrhsSqVNOOZw-e1749632256629.jpg
533
948
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-11 08:59:342025-06-11 08:59:34SpliceBio SL secures US$135m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2025/06/Funding-e1749551193361.jpg
203
360
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-10 10:27:022025-06-11 13:32:02Mosanna Therapeutics bags $80m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/06/BIOCAT-scaled-e1749548352746-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-09 06:36:172025-06-09 06:36:17Spanish BIO-CAT cluster starts new ATMP accelerator
https://european-biotechnology.net/wp-content/uploads/2025/06/Amphistar-Handshake-between-Pierre-Franck-Valentin-CEO-of-AmphiStar-and-Serge-Rogasik-CEO-of-Kensing-e1749210785289-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-06 15:07:262025-06-06 15:07:26Big deal: Amphistar goes transatlantic
https://european-biotechnology.net/wp-content/uploads/2025/06/EFPIA-e1749106985114-1030x551-1.png
551
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-05 07:11:012025-06-05 07:11:01Pharma industry calls EU pharma package counterproductive
https://european-biotechnology.net/wp-content/uploads/2025/06/BMS-headquarters.jpg
169
299
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-04 05:44:582025-06-04 05:44:58Super deal for BioNTech – BMS licenses potential blockbuster for €10bn
https://european-biotechnology.net/wp-content/uploads/2025/06/Scotland_FlexBIO-team-1030x685-1.png
685
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-03 10:55:132025-06-03 10:55:13Scotland’s bioeconomy gets scale-up boost
https://european-biotechnology.net/wp-content/uploads/2025/06/Genentech_1000_F_393222736_571kUgoVIqB7Nv7TWZsuyTNlQbhibyDW.jpg
667
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-06-02 07:46:412025-06-02 07:46:41Scientists uncover target to stop colitis-induced colorectal cancer
https://european-biotechnology.net/wp-content/uploads/2025/05/EB225_Insight-DoubleValley_Scale-up-Strategy_tg-1030x550-1.png
550
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-30 07:13:382025-05-30 07:13:38EU set to improve investment for biotech start-ups and scale-ups
https://european-biotechnology.net/wp-content/uploads/2025/05/NoMy-e1748430078568-1030x579-1.webp
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-28 11:02:572025-05-28 11:02:57Norwegian Mycelium AS bags €1.25m to scale mycoprotein production
Scroll to top
